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Abstract 
Ethanolic and water extracts from six species of Indian medicinal plants 
mainly distributed in the region of Western Ghats, India such as Morinda 
citrifolia (leaf), Garcinia indica (leaf), Garcinia cambogia (leaf), Salacia 
oblonga (leaf), Coccinium fenestratum (stem bark) and Calophyllum 
inophyllum (bark) were tested for their inhibitory activities against two prime 
enzymes of HIV which are HIV-1 protease (HIV-PR) and HIV-1 integrase 
(HIV-IN). The results revealed that the ethanolic and water extract of the 
bark extract of Calophyllum inophyllum exhibited potent anti-HIV-IN 
activity with IC50 values of 9.8 and 5.6 μg/ml, respectively. Whereas  those 
for anti-HIV-1 PR effect were found to be 63.8 and 16.3 μg/ml, respectively.  
This result strongly supports the basis for the use of C. inophyllum for AIDS 
treatment by local traditional practitioners of Ayurveda and Unani system of 
Indian medicine and it is the first report on HIV-1 Protease and HIV-1 
Integrase enzyme inhibition by this plant extract. 
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Introduction 
In recent years, all other forms of 
immunodeficiency syndrome have been 
overshadowed by an epidemic of severe 
immunodeficiency caused by a retrovirus called 
Human immunodeficiency virus type 1 or HIV-1.  
HIV-1 encodes three enzymes, protease (PR), 
reverse transcriptase (RT) and integrase (IN). 
HIV-1 PR is responsible for processing of viral 
proteins into functional enzymes and structural 
proteins. HIV-1 RT is a multifunctional enzyme 
that transcripts viral RNA into viral DNA, 
whereas HIV-1 IN is responsible for the 
integration of double stranded DNA transcribed 
from viral RNA into the host chromosome [1]. 
With the growing drug resistant strains and side 
effects coupled with the increasing failure of 
synthetic drugs it is of interest to screen for HIV-
1 PR and HIV-1 IN inhibitors from natural 
sources. 
Six medicinal plants mainly distributed in the 
region of Western Ghats, India were screened for 
HIV-1 PR and HIV-1 IN inhibitory activity. They 
are Morinda citrifolia L. (leaf), Garcinia indica 
(Dupetit-Thouars) Choisy (leaf), Garcinia 
cambogia (Gaertn.) Desr. (leaf), Salacia oblonga 
L. (leaf), Coccinium fenestratum (Gaertn.) 
Colebr. (stem bark) and Calophyllum inophyllum 
L. (bark). These plants were selected for 
screening owing to their vast medicinal and 
ethnopharmacological importance. Morinda 
citrifolia, is commonly known as Great Morinda, 
Indian mulberry. Its fruit (noni) has been used in 
tropical regions both as food and folk medicine. 
The recent use of noni as a dietary supplement 
has increased greatly and is reported to have a 
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broad range of therapeutic effects, including 
antibacterial, antiviral, antifungal, antitumor, 
antihelminthetic, analgesic, hypotensive, anti-
inflammatory and immune enhancing effects [2]. 
Garcinia indica (kokam) is an Indian spice, the 
fruit rind of which is used in cooking, cosmetics 
and has several medicinal properties [3]. Also, 
some Tanzanian Garcinia species have been 
shown to possess Anti-HIV-1 Protease inhibitory 
activity [4]. Garcinia cambogia is known to be a 
potential antiobesity agent [5], and has shown 
antiulcer activity [6]. Salacia oblonga is known 
to possess wide spectrum activity against several 
human pathogenic bacteria [7]. Coscinium 
fenestratum is an endangered medicinal plant 
whose stem is known to possess neurotoxic 
activity [8] and antidiabetic activity [9]. Previous 
reports are strongly indicative of Anti HIV-1 
Reverse Transcriptase activity of Calophyllum 
inophyllum. The leaves of this tree collected from 
Malaysia have shown inhibition against HIV-1 
Reverse Transcriptase [10]. The seeds of 
Calophyllum cerasiferum and Calophyllum 
inophyllum have shown to contain coumarins 
which are potent HIV-1 Reverse Transcriptase 
inhibitors [11]. The screening was carried out for 
the search of HIV-1 PR and HIV-1 IN inhibitors 
from natural sources which could lead to the 
discovery of novel molecules. This report is the 
first to describe the Anti-HIV-1 Protease and Anti 
HIV-1 Integrase activity of the bark extract of 
Calophyllum inophyllum.  
Materials and Methods 
Preparation of plant extracts 
Twenty grams of each dried plant were extracted 
two times with water and ethanol separately 
under reflux for 3 h. The solvents were removed 
under reduced pressure to obtain the respective 
dry extracts and then dissolved in 50% Dimethyl 
sulfoxide (DMSO) to form stock solutions of 10 
mg/ml in order to carry out the bioassay.  
Enzymes and chemicals 
Recombinant HIV-1 PR, substrate peptides and 
acetyl pepstatin, were purchased from Sigma 
Chemical Co., St. Louis, USA. 
Recombinant HIV-1 IN was expressed in 
Escherichia coli, purified according to the 
method described by Jenkins [12] and stored at -
80 °C until use. 
Assay of HIV-1 protease inhibitory activity 
This assay was modified from the previously 
reported method [13]. In brief, the recombinant 
HIV-1 PR solution was diluted with a buffer 
composed of a solution containing 50 mM of 
sodium acetate (pH 5.0), 1 mM ethylenediamine 
disodium (EDTA.2Na) and 2 mM 2-
mercaptoethanol (2-ME) and mixed with glycerol 
in the ratio 3:1. The substrate peptides, Arg-Val-
Nle-NH2, was diluted with a buffer solution of 50 
mM sodium acetate (pH 5.0). Two microliters of 
plant extract and four microliters of HIV-1 PR 
solution (0.025 mg/ml) were added to a solution 
containing 2 μl of substrate solution (2 mg/ml), 
and the reaction mixture of 10 μl was incubated 
at 37°C for 1 h. A control reaction was performed 
under the same condition but without the plant 
extract. The reaction was stopped by heating the 
reaction mixture at 90°C for 1 min. Subsequently, 
20 μl of sterile water was added and an aliquot of 
10 μl was analyzed by HPLC using RP-18 
column (4.6 mm X 150 mm i.d., Supelco 516 C-
18-DB 5 μm, USA). Ten microliters of the 
reaction mixture was injected to the column and 
gradiently eluted with acetonitrile (15-40%) and 
0.2% trifluoroacetic acid (TFA) in water, at a 
flow rate of 1.0 ml/min. The elution profile was 
monitored at 280 nm. The retention times of the 
substrate and p-NO2-Phe-bearing hydrolysate 
were 4.709 and 2.733 min, respectively. The 
inhibitory activity of HIV-1 PR was calculated as 
follows :% inhibition = (Acontrol – Asample) X 
100/Acontrol ; whereas A is the relative peak of the 
product hydrolysate. Acetyl pepstatin was used as 
a positive control. 
Assay of HIV-IN inhibitory activity 
Oligonucleotide substrates 
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Oligonucleotides of long terminal repeat donor 
DNA  (LTR-D) and target substrate (TS) DNA 
were purchased from QIAGEN Operon, USA and 
stored at -25°C before use.  The sequence of 
biotinylated LTR donor DNA and its unlabelled 
complement were 5'-biotin-
ACCCTTTTAGTCAGTGTGGAAAATCTCTA
GCAGT-3'(LTR-D1) and 3'-
GAAAATCAGTCACACCTTTTAGAGATCGT
CA-5' (LTR-D2), respectively.  Those of the 
target substrate DNA (digoxigenin-labelled target 
DNA, TS-1) and its 3'-labelled complement were 
5'-TGACCAAGGGCTAATTCACT-digoxigenin 
and digoxigenin-
ACTGGTTCCCGATTAAGTGA-5' (TS-2), 
respectively. 
 
Multiplate integration assay (MIA) 
The integration reaction was evaluated according 
to the method previously described [14]. Briefly, 
a mixture (45 μl) composed of 12 μl of IN buffer 
[containing 150 mM 3-(N-morpholino)propane 
sulfonic acid, pH 7.2 (MOPS), 75 mM MnCl2, 5 
mM dithiothritol (DTT), 25% glycerol and 500 
μg/ml bovine serum albumin], 1 μl of 5 pmol/ml 
digoxigenin-labelled target DNA and 32 μl of 
sterilzed water were added into each well of a 96-
well plate. Subsequently, 6 μl of sample solution 
and 9 μl of 1/5 dilution of integrase enzyme was 
added to the plate and incubated at 37 °C for 80 
min. After wells were washed with PBS four 
times, 100 μl of 500 mU/ml alkaline phosphatase 
(AP) labelled anti-digoxigenin antibody were 
added and incubated at 37°C for 1 h. The plate 
was washed again with washing buffer containing 
0.05% Tween 20 in PBS four times and with PBS 
four times. Then, AP buffer (150 μl) containing 
100 mM Tris-HCl (pH 9.5), 100 mM NaCl, 5 
mM MgCl2 and 10 mM p-nitrophenyl phosphate 
was added to each well and incubated at 37°C for 
1 h. Finally, the plate was measured with a 
microplate reader at a wavelength of 405 nm. A 
control composed of a reaction mixture, 50% 
DMSO and an integrase enzyme, while a blank is 
buffer-E containing 20  mM MOPS (pH 7.2), 400 
mM potassium glutamate, 1 mM 
ethylenediaminetetraacetate disodium salt 
(EDTA·2Na), 0.1% Nonidet-P40 (NP-40), 20% 
glycerol, 1 mM DTT and 4 M urea without the 
integrase enzyme.  Suramin, a polyanionic HIV-1 
IN inhibitor was used as a positive control. 
 
 
 
 
where OD = absorbance detected from each well 
 
Statistics 
For statistical analysis, the results of anti-HIV-1 
PR activity were expressed as mean ± S.D. of 
three determinations, while anti-HIV-1 IN 
activity were mean ± S.D. of four determinations.  
The IC50 values were calculated using the 
Microsoft Excel program. 
Results and Discussion 
Ethanolic- and water extracts from six species of 
Indian medicinal plants including Morinda 
citrifolia (leaf), Garcinia indica (leaf), Garcinia 
cambogia (leaf), Salacia oblonga (leaf), 
Coccinium fenestratum (stem bark) and 
Calophyllum inophyllum (bark) were investigated 
against HIV-1 PR and HIV-1 IN activities (Table 
1).  The result indicated that the aqueous extract 
of Calophyllum inophyllum possessed the most 
potent inhibitory activity against HIV-1 IN with 
an IC50 value of 5.6 μg/ml, followed by its EtOH 
extract with an IC50 value of 9.8 μg/ml. 
Calophyllum inophyllum has been reported to 
possess anti-HIV-1 RT activity.  The active 
compounds responsible for this activity are 
calanolide A and B [10].  Reports show a wide 
range in chemical composition within trees 
growing in different geographical location. The 
use of multivariate statistical analyses (PCA) 
shows geographical distribution of inophyllums 
and indicate those rich in HIV-1 active (+)-
inophyllums. Reports suggests the presence of 
interesting chemotypes which could be used as 
plant source for anti-HIV-1 drugs [16]. 
 
% Inhibition against HIV IN=ODcontrol–ODsamplex100  
ODcontrol 
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Table 1: IC50 values of aqueous and ethanolic extracts of six Indian medicinal plants against HIV-1 IN and 
HIV-1 PR activity 
 
 
The results are IC50 ± S.D., n=4 for HIV-1 IN inhibitory activity ; those of HIV-1 PR activity are IC50 ± 
S.D., n= 4 
 
 
 
 
 
 
 
 
 
 
 
 
Botanical Name 
 
Family Extract               IC50 (μg/ml) + S.D. 
 
HIV-1 IN                            HIV-1 PR
 
Morinda citrifolia 
Morinda citrifolia 
 
Rubiaceae Water 
Ethanol
>100                                    >100 
>100                                    >100 
Garcinia indica 
Garcinia indica 
 
Clusiaceae Water  
Ethanol 
87.8                                     >100          
86.2                                       69.5 
 
Garcinia cambogia 
Garcinia cambogia 
 
Guttiferae Water 
Ethanol
 
>100                                      67.7 
>100                                      70.4 
Salacia oblonga 
Salacia oblonga 
 
Hippocrateaceae Water 
Ethanol
 
37.0                                       63.8         
51.5                                       65.3         
Coscinium fenestratum 
Coscinium fenestratum 
 
Menispermacae Water 
Ethanol
>100                                    >100 
>100                                    >100 
Calophyllum inophyllum 
Calophyllum inophyllum 
 
Clusiaceae Water 
Ethanol
 
5.6                                         16.3 
9.8                                         63.8 
Sumarin(positive control  
for HIV-1 IN) 
 
   
2.2±0.2 
Acetyl pepstatin (positive  
Control for HIV-1 PR) 
 
   
3.4±0.1 
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Fig 1 (a) 
 
 
Fig 1 (b) 
Fig. 1. Dose-concentration dependence against HIV-1 IN (a) and HIV-1 PR (b) of Indian Medicinal plants. GIE = Garcinia 
indica (EtOH extract), GIW = Garcinia indica (water extract), GCE = Garcinia cambogia (EtOH extract), GCW =  Garcinia  
cambogia (water extract), SOE = Salacia oblonga (EtOH extract), SOW = Salacia oblonga (water extract),  CIE = Calophyllum 
inophyllum (EtOH extract), CIW = Calophyllum inophyllum (water extract) 
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In conclusion, the present study supports the use 
of Calophyllum inophyllum for treatment of 
AIDS by traditional practitioners and it is the first 
report for anti-HIV-1 IN and PR activity of this 
plant.  The isolation of active compounds from 
this extract will be further investigated. 
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